NCT04272515 Molecular Characterization for Understanding Biliary Atresia
| NCT ID | NCT04272515 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Institut National de la Santé Et de la Recherche Médicale, France |
| Condition | Biliary Atresia |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2021-02-07 |
| Primary Completion | 2026-02-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2021-02-07 with a primary completion date of 2026-02-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Although considered a rare disease, Biliary Atresia (BA) is the leading cause of neonatal cholestasis and liver transplantation in children. Little is known about the molecular mechanisms that drive BA. The purpose of this study is to collect the fluid samples, explanted liver tissue samples and dermal biopsy samples to enable investigators to perform the genetic and molecular analyses that might point to the gene(s) and cellular pathway involved in etiology of BA disease.
Eligibility Criteria
Inclusion Criteria: * confirmed diagnosis of biliary atresia in patients * parents of BA patients Exclusion Criteria: * no
Frequently Asked Questions
Who can join the NCT04272515 clinical trial?
This trial is open to participants of all sexes, studying Biliary Atresia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04272515 currently recruiting?
Yes, NCT04272515 is actively recruiting participants. Visit ClinicalTrials.gov or contact Institut National de la Santé Et de la Recherche Médicale, France to inquire about joining.
Where is the NCT04272515 trial being conducted?
This trial is being conducted at Paris, France, Paris, France.
Who is sponsoring the NCT04272515 clinical trial?
NCT04272515 is sponsored by Institut National de la Santé Et de la Recherche Médicale, France. The trial plans to enroll 100 participants.